Showing 211-220 of 9866 results for "".
Practice Pearls for PDT
https://practicaldermatology.com/series/pdt-in-practice/practice-pearls-for-pdt/20213/Jill S. Waibel, MD a Miami dermatologist specializing in laser surgery, cosmetic dermatology, and medical dermatology, discusses her background in the use of photodynamic therapy (PDT) and provides insight into off-label PDT treatments she provides her patients. Dr. Waibel is a world-recognized leadAdvances in Wound Care
https://practicaldermatology.com/conferences/maui-derm-2022/maui-derm-2022-video/20040/Robert S. Kirsner, MD, PhD discusses the latest in wound healing science and resulting changes in how leading wound care experts are approaching patient care. From innovative products to greater understanding of the science, there are many options to help patients heal.Initiating Biologics
https://practicaldermatology.com/topics/psoriasis/initiating-biologics/19986/Kara S. Gooding, MMS, PA-C offers an overview of a panel discussion about initiating treatment with biologics. The panel shared real-world applications, plus tips on lab monitoring, managing side effects, and choosing the right biologic.DermWireTV: Derm Salaries Down, Allergan Eyes Soliton, Emsculpt Week
https://practicaldermatology.com/topics/practice-management/dermwiretv-derm-salaries-down-allergan-eyes-soliton-emsculpt-week/19941/Just under half of all physicians in the US are employed in physician-owned medical practices, new data from the American Medical Association show. Medscape’s annual Physician Compensation Report reveals that physicians overall saw a reduction in income due to the COVID-19 pandemic; income for dermDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)Client Education: A Win-Win Marketing Strategy
https://practicaldermatology.com/topics/practice-management/client-education-a-win-win-marketing-strategy/23383/Use your digital outreach to educate patients and build relationships.The Shape of the Contouring Market: Expert Tips on Energy-based Body Treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-shape-of-the-contouring-market-expert-tips-on-energy-based-body-treatments/20332/Experienced clinicians weigh in on their approach to identifying, educating, and treating patients for body contouring.Take Your Video Marketing Strategy to the Next Level
https://practicaldermatology.com/topics/practice-management/take-your-video-marketing-strategy-to-the-next-level/23566/Video is a valuable asset across the internet and even offline.The Power of Digital Marketing in Today’s Aesthetic Space
https://practicaldermatology.com/topics/practice-management/the-power-of-digital-marketing-in-todays-aesthetic-space/23313/Become an Instagram Success in Dermatology Marketing
https://practicaldermatology.com/topics/practice-management/become-an-instagram-success-in-dermatology-marketing/23228/If Facebook is your focus, you could be missing an opportunity.